Conference Description
Rheumatology of the Future: State-of-the-Art Diagnosis, Treatment, and Practice
April 9, 2005
The Ritz Carlton Georgetown
3100 South Street, NW
Washington, DC 20007
(202) 912-4100
Tell a friend about this conference
Download the brochure for this conference
CME Credits 3.0*
Nonrefundable registration fee: $0.
Target Audience: Physicians specializing in rheumatology.
Program Summary:
Rheumatology of the Future is a three-part program designed to increase awareness of diagnostic and treatment options and practice economics. In Part I, New Diagnostics Methods, the presenter will discuss new investigative methods for the diagnosis and management of rheumatic diseases including MRI, CT Scan, ultrasound, and serological markers with the focus on testing done through the rheumatologist’s office. In Part II, New Treatment Choices, the presenter will explain and compare new and emerging therapies for the treatment of rheumatic diseases including RA, Lupus, Psoriatic Arthritis, Ankylosing spondylitis, and osteoporosis. In Part III, Practice Economics and Practice Building for the Future will discuss strategies for structuring a rheumatology practice for the future including utilization of ancillary services (i.e., infusion, MRI, physical therapies, bone densities, clinical research, lab, and products), staffing, and compliance with government regulations.
Learning Objectives:
At the conclusion of this program, participants should be able to:
- discuss new investigative methods for the diagnosis and management of rheumatic diseases including MRI, CT Scan, ultrasound, and serological markers with the focus on testing done through the rheumatologist’s office
- evaluate, discuss and compare new and emerging therapies for the treatment of rheumatic diseases including RA, Lupus, Psoriatic Arthritis, Ankylosing spondylitis, and osteoporosis
- discuss strategies for structuring a rheumatology practice for the future including utilization of ancillary services (i.e., infusion, MRI, physical therapies, bone densities, clinical research, lab, and products), staffing, and compliance with government regulations
Agenda:
8:00 a.m.– 8:45 a.m.
Registration and Continental Breakfast and Welcome
9:45 -10:45
New Treatment Choices in Rheumatic Diseases
10:45-11:00
Break
11:00-Noon
Practice Economics and Practice Building for the Future
Faculty:
Norman Gaylis, MD, FACP, FACR
Program Chair
Clinical Associate Professor,
University of Miami School
of Medicine, President and
Managing Partner, Arthritis and
Rheumatic Disease Specialties
Aventura, Florida
David E. Yocum, MD
Professor of Medicine
Director, Arizona Arthritis Center
Arizona Health Sciences Center
Tucson, Arizona
*Continuing Education Information
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 3 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 3 contact hours, as specified by the Massachusetts Board of
Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.
This program is supported through an unrestricted educational grant from Centocor.
|
